Kite Pharma is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications. Kite has a portfolio of proprietary product candidates designed to stimulate the patient`s own immune system to fight tumor cells. These potential
therapies could provide novel strategies for the treatment and management of a wide range of tumor types.